Literature DB >> 24619469

Pancreatic pain.

Hana Nechutova1, Petr Dite, Marketa Hermanova, Ivo Novotny, Arnost Martinek, Pavel Klvana, Bohumil Kianicka, Miroslav Soucek.   

Abstract

Pain is a common symptom of many diseases. Recently, the pain has been classified and analyzed exactly. Its particular components/types are described to the maximum of their depths and details. That is why each particular pain present in a specific disease (pancreatopathies included) has to be treated according to the presence of the specific type of pain. In diseases of pancreas, there are nociceptive, neuropathic, and inflammatory components of pain participating, frequently. Especially long-lasting, not well-controlled pain sets off the process of neuromodulation. The recent pioneering applications/administrations of various neuromodulatory therapeutic approaches represent the promising discoveries for the treatment of long-term, severe, drug-resistant pain syndromes, including chronic pancreatitis. In this article, we summarized the characteristics of pain, the therapeutic strategy, and algorithms of analgesic treatment (in general and applied for pancreatopathies), including new therapeutic trends and approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24619469     DOI: 10.1007/s10354-014-0265-1

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  42 in total

1.  Pain as a reason to visit the doctor: a study in Finnish primary health care.

Authors:  P Mäntyselkä; E Kumpusalo; R Ahonen; A Kumpusalo; J Kauhanen; H Viinamäki; P Halonen; J Takala
Journal:  Pain       Date:  2001-01       Impact factor: 6.961

2.  Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis.

Authors:  C H Wilder-Smith; L Hill; W Osler; S O'Keefe
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

3.  Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial.

Authors:  Søren Schou Olesen; Stefan A W Bouwense; Oliver H G Wilder-Smith; Harry van Goor; Asbjørn Mohr Drewes
Journal:  Gastroenterology       Date:  2011-04-14       Impact factor: 22.682

4.  Nerve growth factor and its high-affinity receptor in chronic pancreatitis.

Authors:  H Friess; Z W Zhu; F F di Mola; C Kulli; H U Graber; A Andren-Sandberg; A Zimmermann; M Korc; M Reinshagen; M W Büchler
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

5.  Prevalence of pain in general practice.

Authors:  Jan Hasselström; Jenny Liu-Palmgren; Görel Rasjö-Wrååk
Journal:  Eur J Pain       Date:  2002       Impact factor: 3.931

6.  Recent advances in the treatment of pain.

Authors:  Mellar P Davis
Journal:  F1000 Med Rep       Date:  2010-08-19

7.  No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis.

Authors:  A Malesci; E Gaia; A Fioretta; P Bocchia; G Ciravegna; P Cantor; I Vantini
Journal:  Scand J Gastroenterol       Date:  1995-04       Impact factor: 2.423

Review 8.  Pain mechanisms in chronic pancreatitis: of a master and his fire.

Authors:  Ihsan Ekin Demir; Elke Tieftrunk; Matthias Maak; Helmut Friess; Güralp Onur Ceyhan
Journal:  Langenbecks Arch Surg       Date:  2010-12-10       Impact factor: 3.445

9.  Cancer pain management-current status.

Authors:  Deepak Thapa; V Rastogi; Vanita Ahuja
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04

10.  Neuromodulatory processes of the brain-gut axis.

Authors:  Alexandru Gaman; Braden Kuo
Journal:  Neuromodulation       Date:  2008-10-01
View more
  2 in total

1.  Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis.

Authors:  Yuhei Irie; Maho Tsubota; Hiroyasu Ishikura; Fumiko Sekiguchi; Yuka Terada; Toshifumi Tsujiuchi; Keyue Liu; Masahiro Nishibori; Atsufumi Kawabata
Journal:  J Neuroimmune Pharmacol       Date:  2017-07-28       Impact factor: 4.147

2.  Nitric Oxide Stimulates Acute Pancreatitis Pain via Activating the NF-κB Signaling Pathway and Inhibiting the Kappa Opioid Receptor.

Authors:  Mengwen Xue; Liang Han; Weikun Qian; Jie Li; Tao Qin; Ying Xiao; Qingyong Ma; Jiguang Ma; Xin Shen
Journal:  Oxid Med Cell Longev       Date:  2020-05-07       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.